Login

Interview with Brian Cox, SurgePays CEO, regarding $SURG.|Kevin Brian Cox. Chairman/CEO, SurgePays Inc ; 00:10:00

Share On Facebook Share On Twitter

Kevin Brian Cox. Chairman/CEO, SurgePays Inc ;

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Key Measures for Portugal's Response to Ambitious Renewable Energy Goals | João Manso Neto, CEO, Greenvolt Energias Renovaveis SA.
00:10:00
Simple Steps to Avoid Probate: Essential Estate Planning Tips | Sarah Kang, Certified Financial Planner of UAK Diversified Wealth Advisors
00:10:00
Champion Iron Eyes Expansion in High-Grade Iron Ore for Decarbonizing Steel Industry | David Cataford, CEO , Champion Iron Ltd.
00:10:00
Take Control with YourOwn Wallet | Nate Hoskin - Founder & Lead Advisor of Hoskin Capital
00:10:00
Mentoring Excellence at Sullivan & Cromwell | William Nelson Cromwell - American attorney & Founder of Sullivan & Cromwell LLP
00:10:00
Borosil Limited's Compassionate Support for Families of Employees Lost to COVID-19 | Shreevar Kheruka, Chairman, Borosil Ltd.
00:10:00
Exclusive Insights from Fairness Resources: CEO David Discusses Exciting Developments and Future Plans at the One-to-One Mining Investment Conference
00:10:00
Aims to open VC funding to tenacious and ambitious female founders|Jennifer Keiser Neundorfer,Co-Founder and Managing Partner,January Ventures
00:10:00
The Evolution and Growth of Red Diamond Executive Headhunters: A Focus on Relationships and Future Planning
00:10:00
Expert Perspectives on Active ETFs and Market Strategies with Noah Hammond | Noah Hamman, CEO ,  AdvisorShares Investments, LLC.
00:10:00
From Marine Scientist to Coast Guard Aviator: A Journey of Service Inspired by 9/11|Captain K.R. Reinhold
00:10:00
I speak with RingCentral Founder Vlad Shmunis and CEO Tarek Robbiati about how the platform will differentiate itself in a crowded market.

© 2017 - Neuhu+